Showing 1 - 6 results of 6 for search 'Gertjan Wolbink', query time: 0.02s Refine Results
  1. 1
    Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at risk

    Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at risk by Gertjan Wolbink, Theo Rispens, Dirkjan van Schaardenburg, Laurette van Boheemen, Pleuni Ooijevaar-De Heer, Nienke Oskam, Dorien Kos

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Reference intervals of work ability and productivity loss and their use in patients with inflammatory rheumatic and musculoskeletal diseases

    Reference intervals of work ability and productivity loss and their use in patients with inflammatory rheumatic and musculoskeletal diseases by Casper Webers, Sofia Ramiro, Annelies Boonen, Gertjan Wolbink, Elena Nikiphorou, Dafne Capelusnik, Laura Boekel, Wouter Smeets, Roel Braekers

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Different rheumatoid factor binding patterns distinguish between Sjögren’s disease with or without associated RA

    Different rheumatoid factor binding patterns distinguish between Sjögren’s disease with or without associated RA by Hendrika Bootsma, Gertjan Wolbink, Theo Rispens, Pleuni Ooijevaar-De Heer, Ninotska I L Derksen, Gwenny Verstappen, Nienke Oskam, Frans Kroese

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients

    The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients by Mateusz Makuch, Josine van Beek, Josine van Beek, Carla A. Wijbrandts, Marja Aalbers, Philippe Stas, Alexander B. Meijer, Anja ten Brinke, Theo Rispens, Paul Peter Tak, Paul Peter Tak, Gertjan Wolbink, Gertjan Wolbink, Janine Schuurman, Paul W. H. I. Parren, Paul W. H. I. Parren, S. Marieke van Ham, S. Marieke van Ham

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Pharmacokinetic Model‐Informed Precision Dosing of Natalizumab in Multiple Sclerosis

    Pharmacokinetic Model‐Informed Precision Dosing of Natalizumab in Multiple Sclerosis by Stefan P. H. van denBerg, Alyssa A. Toorop, Femke Hooijberg, Gertjan Wolbink, Nivea M. F. Voelkner, Liza M. Y. Gelissen, Joep Killestein, Zoé L. E. vanKempen, Thomas P. C. Dorlo, Theo Rispens

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination

    TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination by Sander W Tas, Taco W Kuijpers, Gertjan Wolbink, Theo Rispens, Anja Ten Brinke, Juan J Garcia-Vallejo, S Marieke van Ham, Mark Löwenberg, Luuk Wieske, Laura Boekel, Filip Eftimov, Eileen W Stalman, Maurice Steenhuis, Adriaan G Volkers, Christine Kreher, Lisan H Kuijper, Mariël C Duurland, Laura Fernández Blanco, Amélie Bos, Charlotte Menage, Tineke Jorritsma, Marit J van Gils, Mathieu Claireaux, Geert RAM D’Haens, Laura YL Kummer, Niels JM Verstegen, Veronique AL Konijn, Maryse Tempert, Koos PJ van Dam

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: